Determination of the angiotensin-converting enzyme inhibitor lisinopril in urine using solid-phase extraction and reversed-phase high-performance liquid chromatography
Authors:
- 17 November 1995
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 673 (2) , 306-310
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- High-performance liquid chromatographic determination of amoxicillin in urine using solid-phase, ion-pair extraction and ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- Angiotensin Converting Enzyme Inhibition in Heart, Kidney, and Serum Studied Ex Vivo after Administration of Zofenopril, Captopril, and LisinoprilJournal of Cardiovascular Pharmacology, 1991
- Pharmacokinetics of lisinopril (IV/PO) in healthy volunteersBiopharmaceutics & Drug Disposition, 1989
- LisinoprilDrugs, 1988
- Flow-injection spectrophotometric determination of enalapril in pharmaceuticals with bromothymol blueAnalytica Chimica Acta, 1985
- Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.British Journal of Clinical Pharmacology, 1982
- Effect of molecular structure and conformational change of proline-containing dipeptides in reversed-phase chromatographyJournal of Chromatography A, 1982